Vascular characterization of mice with endothelial expression of cytochrome P450 4F2

FASEB Journal

Volumn 28, Issue 7, 2014, Pages 2915-2931

  Cheng, Jennifer ^a   Edin, Matthew L ^a   Hoopes, Samantha L ^a   Li, Hong ^a   Bradbury, J Alyce ^a   Graves, Joan P ^a   DeGraff, Laura M ^a   Lih, Fred B ^a   Garcia, Victor ^c   Shaik, Jafar Sadik B ^e   Tomer, Kenneth B ^a   Flake, Gordon P ^a   Falck, John R ^b   Lee, Craig R ^d   Poloyac, Samuel M ^e   Schwartzman, Michal L ^c   Zeldin, Darryl C ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

20 HETE; Angiogenesis; Cellular proliferation; CYP4F2; Oxidative stress

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; 8 ISOPROSTAGLANDIN F2 ALPHA; CYTOCHROME; CYTOCHROME P450 4F2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL FUNCTION; BLOOD VESSEL PERMEABILITY; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME MECHANISM; ENZYME SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TANDEM MASS SPECTROMETRY; TRANSGENIC MOUSE; UPREGULATION; VASCULAR DISEASE; VASCULARIZATION; VASOCONSTRICTION; VASODILATATION; WILD TYPE;

20-HETE; ANGIOGENESIS; CELLULAR PROLIFERATION; CYP4F2; OXIDATIVE STRESS;

ANIMALS; BLOOD PRESSURE; CELLS, CULTURED; CYTOCHROME P-450 ENZYME SYSTEM; CYTOKINES; ENDOTHELIAL CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFLAMMATION; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NADPH OXIDASE; NEOVASCULARIZATION, PATHOLOGIC; OXIDATIVE STRESS; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84903744573     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-241927     Document Type: Article

References (44)

1. Cheng, J., Wu, C. C, Gotlinger, K H., Zhang, F., Falck, J. R., Narsimhaswamy, D., and Schwartzman, M. L. (2010) 20-hy-droxy-5, 8, 11, 14-eicosatetraenoic acid mediates endothelial dysfunction via IKB kinase-dependent endothelial nitric-oxide synthase uncoupling. J. Pharmacol. Exp. Ther. 332, 57-65
2. Chen, Y., Medhora, M., Falck, J. R., Pritchard, K A., Jr., and Jacobs, E. R. (2006) Mechanisms of activation of eNOS by 20-HETE and VEGF in bovine pulmonary artery endothelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 291, L378-L385 (Pubitemid 44343713)
3. Miyata, N., and Roman, R. J. (2005) Role of 20-hydroxyeicosa-tetraenoic acid (20-HETE) in vascular system. J. Smooth Muscle Res. 41, 175-193 (Pubitemid 41596358)
4. + channel via a PKC-dependent mechanism in cardi-omyocytes. Am. J. Physiol. Heart Circ. Physiol. 299, H1109-H1117
5. Cheng, J., Ou, J. S., Singh, H., Falck, J. R., Narsimhaswamy, D., Pritchard, K A., Jr., and Schwartzman, M. L. (2008) 20-hydroxy-eicosatetraenoic acid causes endothelial dysfunction via eNOS uncoupling. Am. J. Physiol. Heart Circ. Physiol. 294, H1018-H1026 (Pubitemid 351253316)
6. Singh, H., Cheng, J., Deng, H., Kemp, R., Ishizuka, T., Nasjletti, A, and Schwartzman, M. L. (2007) Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension. Hypertension 50, 123-129 (Pubitemid 46986020)
7. Jacobs, E. R., Zhu, D., Gruenloh, S., Lopez, B., and Medhora, M. (2006) VEGF-induced relaxation of pulmonary arteries is mediated by endothelial cytochrome P-450 hydroxylase. Am. J. Physiol. Lung Cell. Mol. Physiol. 291, L369-L377 (Pubitemid 44343712)
8. Medhora, M., Chen, Y., Gruenloh, S., Harland, D., Bodiga, S., Zielonka, J., Gebremedhin, D., Gao, Y, Falck, J. R., Anjaiah, S., and Jacobs, E. R. (2008) 20-HETE increases superoxide production and activates NAPDH oxidase in pulmonary artery endothelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 294, L902-L911
9. Guo, A. M., Arbab, A. S., Falck, J. R., Chen, P., Edwards, P. A., Roman, R. J., and Scicli, A. G. (2007) Activation of vascular endothelial growth factor through reactive oxygen species mediates 20-hydroxyeicosatetraenoic acid-induced endothelial cell proliferation. J. Pharmacol. Exp. Ther. 321, 18-27 (Pubitemid 46456964)
10. Chen, P., Guo, M., Wygle, D., Edwards, P. A., Falck, J. R., Roman, R. J., and Scicli, A. G. (2005) Inhibitors of cytochrome P450 4A suppress angiogenic responses. Am. J. Pathol. 166, 615-624 (Pubitemid 40189056)
11. Park, F., Sweeney, W. E., Jia, G., Roman, R. J., and Avner, E. D. (2008) 20-HETE mediates proliferation of renal epithelial cells in polycystic kidney disease. J. Am. Soc. Nephrol. 19, 1929-1939
12. Amaral, S. L., Maier, K G., Schippers, D. N., Roman, R. J., and Greene, A. S. (2003) CYP4A metabolites of arachidonic acid and VEGF are mediators of skeletal muscle angiogenesis. Am. J. Physiol. Heart Circ. Physiol. 284, H1528-H1535 (Pubitemid 36460763)
13. Jiang, M., Mezentsev, A., Kemp, R., Byun, K, Falck, J. R., Miano, J. M., Nasjletti, A., Abraham, N. G., and Laniado-Schwartzman, M. (2004) Smooth muscle-specific expression of CYP4A1 induces endothelial sprouting in renal arterial microvessels. Circ. Res. 94, 167-174 (Pubitemid 38197448)
14. Yu, W., Chen, L., Yang, Y. Q., Falck, J. R., Guo, A. M., Li, Y, and Yang, J. (2011) Cytochrome P450 omega-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer. Cancer Chemother. Pharmacol. 68, 619-629
15. Ishizuka, T., Cheng, J., Singh, H., Vitto, M. D., Manthati, V. L., Falck, J. R., and Laniado-Schwartzman, M. (2008) 20-hydroxyeicosatetraenoic acid stimulates nuclear factor-KB activation and the production of inflammatory cytokines in human endothelial cells. J. Pharmacol. Exp. Ther. 324, 103-110 (Pubitemid 350294158)
16. Hoff, U., Lukitsch, I., Chaykovska, L., Ladwig, M., Arnold, C, Manthati, V. L., Fuller, T. F., Schneider, W., Gollasch, M., Muller, D. N., Flemming, B., Seeliger, E., Luft, F. C., Falck, J. R., Dragun, D., and Schunck, W. H. (2011) Inhibition of 20-HETE synthesis and action protects the kidney from ischemia/reper-fusion injury. Kidney Int. 79, 57-65
17. Powell, P. K., Wolf, I., Jin, R., and Lasker, J. M. (1998) Metabolism of arachidonic acid to 20-hydroxy-5, 8, 11, 14-eicosa-tetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11. J. Pharmacol. Exp. Ther. 285, 1327-1336 (Pubitemid 28277936)
18. Lasker, J. M., Chen, W. B., Wolf, I., Bloswick, B. P., Wilson, P. D., and Powell, P. K. (2000) Formation of 20-hydroxyeicosatetra-enoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11. J. Biol. Chem. 275, 4118-4126 (Pubitemid 30094644)
19. Ward, N. C., Tsai, I. J., Barden, A., van Bockxmeer, F. M., Puddey, I. B., Hodgson, J. M., and Croft, K. D. (2008) A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 gene is associated with increased 20-HETE excretion and blood pressure. Hypertension 51, 1393-1398 (Pubitemid 351555955)
20. Deng, S., Zhu, G., Liu, F., Zhang, H., Qin, X., Li, L., and Zhiyi, H. (2010) CYP4F2 gene V433M polymorphism is associated with ischemic stroke in the male northern Chinese Han population. Prog. Neuropsychopharmacol. Biol. Psychiatry 34, 664-668
21. Liu, H., Zhao, Y., Nie, D., Shi, J., Fu, L., Li, Y., Yu, D., and Lu, J. (2008) Association of a functional cytochrome P450 4F2 haplo-type with urinary 20-HETE and hypertension. J. Am. Soc. Nephrol. 19, 714-721
22. Liu, X., Zhao, Y., Wang, L., Yang, X., Zheng, Z., Zhang, Y., Chen, F., and Liu, H. (2009) Overexpression of cytochrome P450 4F2 in mice increases 20-hydroxyeicosatetraenoic acid production and arterial blood pressure. Kidney. Int. 75, 1288-1296
23. Ward, N. C., Puddey, I. B., Hodgson, J. M., Beilin, L. J., and Croft, K. D. (2005) Urinary 20-hydroxyeicosatetraenoic acid excretion is associated with oxidative stress in hypertensive subjects. Free Radic. Biol. Med. 38, 1032-1036 (Pubitemid 40386549)
24. Ward, N. C., Rivera, J., Hodgson, J., Puddey, I. B., Beilin, L. J., Falck, J. R., and Croft, K. D. (2004) Urinary 20-hydroxyeicosa-tetraenoic acid is associated with endothelial dysfunction in humans. Circulation 110, 438-443 (Pubitemid 38993854)
25. Schuck, R. N., Theken, K. N., Edin, M. L., Caughey, M., Bass, A., Ellis, K., Tran, B., Steele, S., Simmons, B. P., Lih, F. B., Tomer, K. B., Wu, M. C., Hinderliter, A. L., Stouffer, G. A., Zeldin, D. C., and Lee, C. R. (2013) Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patients. Atherosclerosis 227, 442-448
26. Lee, C. R., Imig, J. D., Edin, M. L., Foley, J., DeGraff, L. M., Bradbury, J. A., Graves, J. P., Lih, F. B., Clark, J., Myers, P., Perrow, A. L., Lepp, A. N., Kannon, M. A., Ronnekleiv, O. K., Alkayed, N. J., Falck, J. R., Tomer, K. B., and Zeldin, D. C. (2010) Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice. FASEB J. 24, 3770-3781
27. Athirakul, K., Bradbury, J. A., Graves, J. P., DeGraff, L. M., Ma, J., Zhao, Y., Couse, J. F., Quigley, R., Harder, D. R., Zhao, X., Imig, J. D., Pedersen, T. L., Newman, J. W., Hammock, B. D., Conley, A. J., Korach, K. S., Coffman, T. M., and Zeldin, D. C. (2008) Increased blood pressure in mice lacking cytochrome P450 2J5. FASEB J. 22, 4096-4108
28. Edin, M. L., Wang, Z., Bradbury, J. A., Graves, J. P., Lih, F. B., DeGraff, L. M., Foley, J. F., Torphy, R., Ronnekleiv, O. K., Tomer, K. B., Lee, C. R., and Zeldin, D. C. (2011) Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart. FASEB J. 25, 3436-3447
29. Livak, K. J., and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402-408 (Pubitemid 34164012)
30. Wang, J. S., Singh, H., Zhang, F., Ishizuka, T., Deng, H., Kemp, R., Wolin, M. S., Hintze, T. H., Abraham, N. G., Nasjletti, A., and Laniado-Schwartzman, M. (2006) Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus. Circ. Res. 98, 962-969
31. Wassmann, S., Stumpf, M., Strehlow, K., Schmid, A., Schieffer, B., Bohm, M., and Nickenig, G. (2004) Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor. Circ. Res. 94, 534-541 (Pubitemid 38326289)
32. Behrens, M. M., Ali, S. S., and Dugan, L. L. (2008) Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia. J. Neurosci. 28, 13957-13966
33. ten Freyhaus, H., Huntgeburth, M., Wingler, K., Schnitker, J., Baumer, A. T., Vantler, M., Bekhite, M. M., Wartenberg, M., Sauer, H., and Rosenkranz, S. (2006) Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation. Cardiovasc. Res. 71, 331-341
34. Olsson, A. K., Dimberg, A., Kreuger, J., and Claesson-Welsh, L. (2006) VEGF receptor signalling-in control of vascular function. Nat. Rev. Mol. Cell Biol. 7, 359-371
35. Liu, X., Wu, J., Liu, H., Lai, G., and Zhao, Y. (2012) Disturbed ratio of renal 20-HETE/EETs is involved in androgen-induced hypertension in cytochrome P450 4F2 transgenic mice. Gene 505, 352-359
36. Cheng, J., Garcia, V., Ding, Y., Wu, C. C., Thakar, K., Falck, J. R., Ramu, E., and Schwartzman, M. L. (2012) Induction of angio-tensin-converting enzyme and activation of the renin-angiotensin system contribute to 20-hydroxyeicosatetraenoic acid-mediated endothelial dysfunction. Arterioscler. Thromb. Vasc. Biol. 32, 1917-1924
37. Inoue, K., Sodhi, K., Puri, N., Gotlinger, K. H., Cao, J., Rezzani, R., Falck, J. R., Abraham, N. G., and Laniado-Schwartzman, M. (2009) Endothelial-specific CYP4A2 overexpression leads to renal injury and hypertension via increased production of 20-HETE. Am. J. Physiol. Renal Physiol. 297, F875-F884
38. Hankin, J. A., and Murphy, R. C. (2000) The metabolism of leukotriene B4 in Lewis lung carcinoma porcine kidney cells. Am. J. Respir. Crit. Care Med. 161, S81-S87 (Pubitemid 30129422)
39. Zalba, G., San Jose, G., Moreno, M. U., Fortuno, M. A., Fortuno, A, Beaumont, F. J., and Diez, J. (2001) Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension38, 1395-1399 (Pubitemid 34033422)
40. Lassegue, B., and Griendling, K. K. (2010) NADPH oxidases: functions and pathologies in the vasculature. Arterioscler. Thromb. Vasc. Biol. 30, 653-661
41. Uddin, M. R., Muthalif, M. M., Karzoun, N. A., Benter, I. F., and Malik, K. U. (1998) Cytochrome P-450 metabolites mediate norepinephrine-induced mitogenic signaling. Hypertension 31, 242-247
42. Guo, A. M., Scicli, G., Sheng, J., Falck, J. C, Edwards, P. A., and Scicli, A. G. (2009) 20-HETE can act as a nonhypoxic regulator of HIF-1a in human microvascular endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 297, H602-H613
43. Alexanian, A., Rufanova, V. A., Miller, B., Flasch, A., Roman, R. J., and Sorokin, A. (2009) Down-regulation of 20-HETE synthesis and signaling inhibits renal adenocarcinoma cell proliferation and tumor growth. Anticancer Res. 29, 3819-3824
44. Alexanian, A., Miller, B., Roman, R. J., and Sorokin, A. (2012) 20-HETE-producing enzymes are up-regulated in human cancers. Cancer Genomics Proteomics 9, 163-169